A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

ClinicalTrials.gov ID: NCT06855771

Public ClinicalTrials.gov record NCT06855771. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of BMS-986504 Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies

Study identification

NCT ID: NCT06855771
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 130 participants

Conditions and interventions

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

BMS-986504 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 8, 2025
Primary completion: Dec 28, 2028
Completion: Dec 29, 2031
Last update posted: Apr 29, 2026

2025 – 2031

United States locations

U.S. sites: 12
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
Alaska Oncology and Hematology	Anchorage	Alaska	99508	Recruiting
Local Institution - 0099	Boise	Idaho	83712	Not yet recruiting
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
Washington University School of Medicine	St Louis	Missouri	63110	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
Local Institution - 0079	Shirley	New York	11967	Not yet recruiting
Gabrail Cancer Center	Canton	Ohio	44718	Recruiting
Providence Portland Medical Center	Portland	Oregon	97213	Recruiting
Oregon Health and Science University	Portland	Oregon	97239	Recruiting
Fred Hutchison Cancer Center	Seattle	Washington	98109	Recruiting
Local Institution - 0084	Milwaukee	Wisconsin	53226	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06855771, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 29, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06855771 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →